These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The effect of recombinant interleukin-8 on eosinophils' and neutrophils' migration in vivo and in vitro. Bocheńska-Marciniak M, Kupczyk M, Górski P, Kuna P. Allergy; 2003 Aug; 58(8):795-801. PubMed ID: 12859561 [Abstract] [Full Text] [Related]
3. Interleukin-8 secretion in patients with allergic rhinitis after an allergen challenge: interleukin-8 is not the main chemotactic factor present in nasal lavages. Gosset P, Tillie-Leblond I, Malaquin F, Durieu J, Wallaert B, Tonnel AB. Clin Exp Allergy; 1997 Apr; 27(4):379-88. PubMed ID: 9146930 [Abstract] [Full Text] [Related]
4. Effects of TNFalpha on the human nasal mucosa in vivo. Widegren H, Korsgren M, Andersson M, Greiff L. Respir Med; 2007 Sep; 101(9):1982-7. PubMed ID: 17532197 [Abstract] [Full Text] [Related]
5. IL-8 and the activation of eosinophils and neutrophils following nasal allergen challenge. Jacobi HH, Poulsen LK, Reimert CM, Skov PS, Ulfgren AK, Jones I, Elfman LB, Malling HJ, Mygind N. Int Arch Allergy Immunol; 1998 May; 116(1):53-9. PubMed ID: 9623510 [Abstract] [Full Text] [Related]
15. Nasal neutrophilia and release of myeloperoxidase induced by nasal challenge with platelet activating factor: different degrees of responsiveness in atopic and nonatopic subjects. Miadonna A, Milazzo N, Lorini M, Sala A, Tedeschi A. J Allergy Clin Immunol; 1996 Apr; 97(4):947-54. PubMed ID: 8655890 [Abstract] [Full Text] [Related]
18. Applicability and reproducibility of biomarkers for the evaluation of anti-inflammatory therapy in allergic rhinitis. Boot JD, Chandoesing P, de Kam ML, Mascelli MA, Das AM, Gerth van Wijk R, de Groot H, Verhoosel R, Hiemstra PS, Diamant Z. J Investig Allergol Clin Immunol; 2008 Apr; 18(6):433-42. PubMed ID: 19123434 [Abstract] [Full Text] [Related]